J.W. Cole Advisors, Inc. Bristol Myers Squibb CO Transaction History

J.W. Cole Advisors, Inc.

$4.58 Billion
Q2 2025

A detailed history of J.W. Cole Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 70,431 shares of BMY stock, worth $3.24 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

70,431

Previous 61,851 13.87%

Holding current value

$3.24 Million

Previous $3.77 Million 13.57%

% of portfolio

0.07%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$44.12 - $59.6 $378,549 - $511,368	8,580 Added 13.87%	70,431 $3.26 Million
Q1 2025 May 05, 2025	BUY	$53.9 - $63.11 $2.25 Million - $2.63 Million	41,730 Added 207.4%	61,851 $3.77 Million
Q4 2024 Jan 30, 2025	BUY	$51.92 - $59.94 $13,447 - $15,524	259 Added 1.3%	20,121 $1.14 Million
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $164,390 - $214,503	-4,145 Reduced 17.27%	19,862 $1.03 Million
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $266,535 - $350,899	-6,622 Reduced 21.62%	24,007 $997,000
Q1 2024 Apr 30, 2024	SELL	$47.98 - $54.4 $57,671 - $65,388	-1,202 Reduced 3.78%	30,629 $1.66 Million
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $134,435 - $160,418	2,773 Added 9.54%	31,831 $1.63 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $142,872 - $159,753	2,468 Added 9.28%	29,058 $1.69 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $135,128 - $150,039	-2,121 Reduced 7.39%	26,590 $1.7 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $45,077 - $51,127	686 Added 2.45%	28,711 $1.99 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $60,330 - $71,440	881 Added 3.25%	28,025 $2.02 Million
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $10 - $6,454	-84 Reduced 0.31%	27,144 $1.93 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $136,743 - $150,602	1,883 Added 7.43%	27,228 $2.1 Million
Q1 2022 Jun 10, 2022	SELL	$61.48 - $73.72 $113 Million - $135 Million	-1,831,730 Reduced 98.64%	25,345 $1.85 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $112 Million - $135 Million	1,826,259 Added 5926.33%	1,857,075 $880,000
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $30,837 - $35,949	-575 Reduced 1.83%	30,816 $1.92 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $264,134 - $309,399	4,464 Added 16.58%	31,391 $1.86 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $266,708 - $290,445	-4,308 Reduced 13.79%	26,927 $1.8 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $71,920 - $80,888	-1,212 Reduced 3.74%	31,235 $1.97 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $3.24 Million - $3.67 Million	-56,075 Reduced 63.35%	32,447 $2.01 Million
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $3.53 Million - $3.91 Million	61,421 Added 226.64%	88,522 $5.34 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $1.49 Million - $1.74 Million	27,101 New	27,101 $1.59 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $1.89 Million - $2.75 Million	-40,725 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $2 Million - $2.61 Million	40,725 New	40,725 $2.61 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.64B

Call Options Held

22.5M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Bristol Myers Squibb CO Transaction History